TScan Therapeutics (TCRX) Cash from Financing Activities (2020 - 2025)
TScan Therapeutics (TCRX) recorded Cash from Financing Activities of $73,000 in Q4 2025, down 99.8% from $45.69 million a year earlier.
Powered by 
Analysis
TScan Therapeutics (TCRX) Cash from Financing Activities (2020 - 2025) Analysis & Trends
For FY2025, TScan Therapeutics reported Cash from Financing Activities of -$336,000.
- Across earlier years, Cash from Financing Activities came in at $208.77 million in FY2024 (+54.1%), $135.44 million in FY2023 (+361.4%), $29.36 million in FY2022 (-84.5%) and $189.67 million in FY2021.
- Quarterly Cash from Financing Activities has ranged from -$686,000 in Q2 2021 to $161.59 million in Q2 2024 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | TScan Therapeutics | 40.28 Mn | 40.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 73,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | -525,000.00 |
| Dec 31, 2024 | 45.69 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 161.59 Mn |
| Mar 31, 2024 | 258,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | -252,000.00 |
| Dec 31, 2022 | 108,000.00 |
| Sep 30, 2022 | 29.13 Mn |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 88,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | 90.61 Mn |
| Jun 30, 2021 | -686,000.00 |
| Mar 31, 2021 | 99.63 Mn |
| Dec 31, 2020 | 40,000.00 |
| Sep 30, 2020 | 1,000.00 |
API Access
TScan Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();